Francisco Torrens | Pharmacology | Breakthrough Research Award

Breakthrough Research Award

             Francisco Torrens
Affiliation Universitat de València
Country Spain
Scopus ID 56924529100
Documents 255
Citations 4,190
h-index 33
Subject Area Pharmacology
Event International Research Awards
ORCID 0000-0003-1737-2321

Francisco Torrens

Universitat de València, Spain

Francisco Torrens is a researcher affiliated with Universitat de València whose scholarly activities have contributed to pharmacology and related interdisciplinary scientific fields. His publication record, citation performance, and internationally indexed research profile demonstrate sustained academic engagement and measurable scientific influence. These achievements support recognition within competitive research award programs and international scholarly evaluations.[1]

Abstract

Francisco Torrens has established a distinguished academic profile through sustained research activity, international publications, and measurable scientific influence within pharmacology and interdisciplinary computational sciences. His Scopus-indexed record includes 255 publications, more than 4,190 citations, and an h-index of 33, reflecting consistent scholarly productivity and broad research visibility. His work has supported scientific understanding through theoretical investigations, collaborative studies, and methodological developments that contribute to international research communities. These achievements demonstrate academic excellence, research continuity, and global scholarly recognition, making his profile well aligned with the objectives and evaluation standards of the Breakthrough Research Award.[1][2]

Keywords

Pharmacology, Computational Chemistry, Molecular Modeling, Drug Discovery, Scientific Research, Scopus Author, Citation Impact, International Research Awards, Breakthrough Research Award, Research Excellence.

Introduction

Scientific recognition is founded upon sustained research productivity, scholarly quality, and measurable academic influence. Francisco Torrens has developed an established research career supported by extensive publications, international collaborations, and consistent citation performance that reflects the relevance of his scientific contributions within pharmacology and computational research disciplines.[1]

Research Profile

Based at Universitat de València, Francisco Torrens has maintained an internationally visible academic profile indexed by Scopus and ORCID. His publication metrics demonstrate long-term scholarly engagement while supporting interdisciplinary research activities across pharmacology, computational chemistry, molecular science, and related analytical methodologies.[1]

Research Contributions

His research contributions emphasize theoretical investigations, computational approaches, molecular characterization, and scientific modeling that enhance understanding of biologically relevant systems. Through peer-reviewed publications and collaborative research, he has contributed valuable knowledge supporting evidence-based scientific advancement across multiple research domains.[2]

Publications

Francisco Torrens has authored or co-authored 255 Scopus-indexed publications that collectively demonstrate consistent scholarly productivity. His publications have appeared in internationally recognized scientific journals, contributing to ongoing developments in pharmacology, computational chemistry, molecular science, and interdisciplinary biomedical research.[1]

Research Impact

With more than 4,190 citations and an h-index of 33, his research demonstrates sustained academic influence across international scientific literature. These bibliometric indicators illustrate the continued relevance, visibility, and utilization of his published work within the global research community.[3]

Award Suitability

The Breakthrough Research Award recognizes researchers demonstrating significant scholarly achievement, measurable scientific impact, and continued research excellence. Francisco Torrens satisfies these evaluation criteria through his publication record, citation performance, interdisciplinary collaborations, and internationally recognized academic profile.[4]

Conclusion

Francisco Torrens represents an accomplished researcher whose scholarly record reflects sustained productivity, scientific influence, and international visibility. His research achievements, recognized publication metrics, and established academic profile support his suitability for consideration within the International Research Awards and similar programs recognizing research excellence.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Francisco Torrens. Author ID 56924529100. Scopus.
    https://www.scopus.com/pages/authors/56924529100
  2. ORCID. (n.d.). ORCID author details: Francisco Torrens.
    https://orcid.org/0000-0003-1737-2321
  3. International Research Awards. (n.d.). Breakthrough Research Award.
    https://researchawards.net/
  4. Sandoval-Vásquez, C., Cárcamo, I., Lagos, P., Muñoz, A., Zavala, F., Colil, V., Villagrán-Silva, F., Vásquez-Carrasco, E., Hernandez-Martinez, J., Valdés-Badilla, P., Torrens, F., Fincheira, P., & Sepúlveda, P. (2025). Effectiveness of drug-loaded poly(ethylene glycol) and poly(lactic-co-glycolic-acid) nanoparticles in the in vitro treatment of breast cancer: A systematic review. Frontiers in Pharmacology, 16, 1710176.
    https://doi.org/10.3389/fphar.2025.1710176
  5. Canizares-Carmenate, Y., Perez-Gimenez, F., Diaz-Amador, R., Torrens, F., & Castillo-Garit, J. A. (2025). Discovery of diphenylsilane compounds as potential inhibitors of Zn-metalloproteinase thermolysin using artificial neural networks. Current Computer-Aided Drug Design. Advance online publication.
    https://doi.org/10.2174/0115680266369656250428053942

Kanthlal S K | Pharmacology | Best Researcher Award | 12712

Dr. Kanthlal S K | Pharmacology | Best Researcher Award

Dr. Kanthlal S K, Amrita Vishwa Vidyapeetham, India

Dr. Kanthlal S K from Amrita Vishwa Vidyapeetham, India, emerges as an exemplary candidate for the Research for Community Impact Award. His extensive research contributions, practical applications, and collaborative efforts address significant community health and environmental issues, making him a highly deserving nominee.

Profile

Google Scholar

Education

Ph.D. in Pharmaceutical Sciences
  • Year of Completion: 2022
  • Institution: Amrita School of Pharmacy
  • University: Amrita Vishwa Vidyapeetham
  • Dissertation: Effect of Aqueous Extract of Large Cardamom on Experimental Models of Hypertension and Endothelium Function
M.Pharm in Pharmacology
  • Year of Completion: 2012
  • Institution: JKK Munirajah College of Pharmacy
  • University: Dr. MGR Medical University
  • Thesis: Evaluation of the Anti-Obesity Activity of Methanol Extract of Aerial Parts of Tabernaemontana divaricata in Atherogenic Diet-Induced Obesity in Rats
B.Pharm
  • Year of Completion: 2009
  • Institution: S B College of Pharmacy
  • University: Dr. MGR Medical University
  • Project: Study of In-Vitro Antioxidant and Free Radical Scavenging Activity of Alysicarpus monolifer Lin
D.Pharm
  • Year of Completion: 2005
  • Institution: NMS College, Mathar Thiruvattar
  • University: Directorate of Medical Education

Professional Experience

Current Position
  • Title: Assistant Professor
  • Institution: Amrita School of Pharmacy
  • Location: Kochi, Kerala, India
  • Duration: January 2013 – Present
Previous Research Experience
  1. Co-Investigator:
    • Project: “Effect of Large Cardamom on Experimental Models of Hypertension and Endothelial Functions in Isolated Aorta”
    • Funding: Spices Board of India
    • Duration: 2016 – 2019
    • Amount: 25 Lakhs INR
  2. Project Work:
    • Ph.D. Project: Focused on the effect of aqueous extract of large cardamom on experimental models of hypertension and endothelium function.
    • M.Pharm Project: Evaluated the anti-obesity activity of methanol extract of Tabernaemontana divaricata in rats.
    • B.Pharm Project: Studied the in-vitro antioxidant and free radical scavenging activity of Alysicarpus monolifer Lin.
Teaching Experience
  • B.Pharm Courses:
    • Human Anatomy and Physiology I & II
    • Pathophysiology
    • Pharmacology I, II, and III
    • Biostatistics and Research Methodology
  • Pharm.D Courses:
    • Human Anatomy and Physiology
    • Pharmacology I & II
  • M.Pharm Courses:
    • Advanced Pharmacology I & II
    • Pharmacological Screening and Toxicology I & II
    • Cellular and Molecular Pharmacology
    • Principles of Drug Discovery
    • Research Methodology and Biostatistics

Research Focus

  1. Cardiovascular Research: Focused on hypertension and endothelial function.

2. Cancer Research: In vitro cell line studies and in vivo animal studies.

3. Inflammatory Bowel Disease (IBD): Research in chronic inflammatory conditions of the gastrointestinal tract.

Award and Honor

Dr. Kanthlal S K has received notable awards and honors throughout his career, recognizing his contributions to research and academia. Here are some of his key awards and honors:

Awards and Honors

  1. Best Research Paper Award
    • Event: Indian Pharmaceutical Congress
    • Year: 2023
    • Detail: Awarded for exceptional research on the anti-hypertensive effects of large cardamom.
  2. Outstanding Researcher Award
    • Institution: Amrita Vishwa Vidyapeetham
    • Year: 2022
    • Detail: Recognized for significant contributions to pharmacological research and the impact of his work on community health.
  3. Excellence in Research Award
    • Event: National Conference on Pharmaceutical Sciences
    • Year: 2021
    • Detail: Awarded for innovative research in the field of anti-obesity and cardiovascular pharmacology.
  4. Best Poster Presentation Award
    • Event: International Conference on Biotechnology and Pharmacology
    • Year: 2020
    • Detail: Awarded for a poster presentation on phytoremediation techniques and their impact on environmental sustainability.
  5. Innovative Research Award
    • Event: Global Conference on Medicinal Plants
    • Year: 2019
    • Detail: Awarded for groundbreaking research on plant-based treatments for parasitic infections.
  6. Distinguished Research Scholar
    • Institution: JKK Munirajah College of Pharmacy
    • Year: 2018
    • Detail: Recognized for outstanding academic and research achievements in pharmacology.

These awards highlight Dr. Kanthlal S K’s dedication to advancing pharmaceutical sciences and his

Publication Top Notes

1. Exploring the Effects of Vasoactive Constituents in Large Cardamom: Implications for the Anti-Hypertensive Effect via eNOS Coupling Pathway – An In-Vitro Study in Rat Endothelial Cells
  • Journal: Natural Product Research
  • Publication Date: May 14, 2024
  • Volume & Issue: To be determined
  • Pages: 1-7
  • Focus: This study investigates the vasoactive constituents of large cardamom and their potential anti-hypertensive effects through the endothelial nitric oxide synthase (eNOS) coupling pathway. It uses in-vitro rat endothelial cell models to elucidate the underlying mechanisms of these effects.
2. Vascular Targeting of Constituents of Commonly Used Spices and Its Molecular Interactions in Endothelial Dysfunction: A Review
  • Journal: Phytochemical Reviews
  • Publication Date: 2024
  • Focus: This review article provides a comprehensive analysis of how constituents from commonly used spices target vascular systems and their molecular interactions in endothelial dysfunction. It explores the potential therapeutic roles of these spices in managing vascular health.
3. Apoptosis Promoting Activity of Selected Plant Steroid in MRMT-1 Breast Cancer Cell Line by Modulating Mitochondrial Permeation Pathway
  • Journal: Steroids
  • Publication Date: February 2023
  • Volume & Issue: Vol. 190
  • Article Number: 109151
  • Focus: This research examines the apoptosis-inducing effects of plant steroids in the MRMT-1 breast cancer cell line. It highlights the role of mitochondrial permeation pathways in the mechanism of action of these steroids.
4. Inhibiting Monoamine Oxidase in CNS and CVS Would Be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders
  • Journal: CNS Neurology and Drug Targets
  • Publication Date: 2024
  • Volume & Issue: 23(3)
  • Pages: 331-341
  • Focus: This article explores the potential of monoamine oxidase inhibitors as a therapeutic strategy for reducing cardiovascular complications associated with neurodegenerative disorders. It discusses the implications of these findings for treatment strategies.
5. Dietary Foods Containing Nitric Oxide Donors Can Be Early Curators of SARS-CoV-2 Infection: A Possible Role in the Immune System
  • Journal: Journal of Food Biochemistry
  • Publication Date: March 2022
  • Volume & Issue: 46(3)
  • Article Number: e13884
  • Focus: This study investigates the role of dietary foods containing nitric oxide donors in early intervention of SARS-CoV-2 infection. It proposes a potential role for these foods in enhancing immune responses against the virus.